Stay updated on Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial

Sign up to get notified when there's something new on the Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    A recruitment-closed banner is now displayed on the page. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) are added, and a formatting change updates 'Intervention / Treatment' to 'Intervention/Treatment' along with a revision stamp to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:28:38.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Page revision tag updated from v3.5.4 to v3.5.5, indicating a maintenance/patch-level update to the page. This change does not alter the visible content or behavior of the page.
    Difference
    0.1%
    Check dated 2026-06-05T12:33:53.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The page shows a new revision tag, v3.5.4, replacing the previous v3.5.3, indicating a small update to the document version. The change affects metadata only and does not modify study details or results.
    Difference
    0.1%
    Check dated 2026-05-15T05:57:47.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The page’s site “Revision” indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T06:12:21.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision upgraded from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:25:48.000Z thumbnail image
  7. Check
    96 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0; no substantive study information changes are evident.
    Difference
    0.1%
    Check dated 2026-03-18T22:28:15.000Z thumbnail image

Stay in the know with updates to Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial page.